• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The newer hematinics, their use and abuse.新型补血药及其使用与滥用
Calif Med. 1952 Dec;77(6):369-73.
2
[Observations on oral therapy of pernicious anemia].[恶性贫血的口服疗法观察]
Med Klin. 1954 Jan 15;49(3):109-11.
3
[Oral therapy of pernicious; clinical experiences with a vitamin B12 folic acid preparation].[恶性贫血的口服疗法;一种维生素B12叶酸制剂的临床经验]
Medizinische. 1953 Mar 7;21(10):326-7.
4
Studies on the mutual effect of suboptimal oral doses of vitamin B12 and folic acid in pernicious anemia.关于恶性贫血中口服次优剂量维生素B12和叶酸相互作用的研究。
N Engl J Med. 1952 Jul 3;247(1):15-7. doi: 10.1056/NEJM195207032470104.
5
Parenteral B12-folic acid therapy in pernicious anemia.恶性贫血的胃肠外维生素B12-叶酸疗法
Ann Intern Med. 1952 Oct;37(4):755-60. doi: 10.7326/0003-4819-37-4-755.
6
[Summation of peroral subminimal doses of vitamin B12 and folic acid in pernicious anemia].[恶性贫血中口服亚最小剂量维生素B12和叶酸的总和]
Munch Med Wochenschr. 1952 Jan 4;94(1):14-7.
7
Long-term evaluation of vitamin B12 in treatment of pernicious anemia. I. Incidental report on use of combined oral therapy with vitamin B12 and folic acid.
J Am Med Assoc. 1955 Jan 15;157(3):229-31. doi: 10.1001/jama.1955.02950200027008.
8
Folic acid and vitamin B12 in pernicious anemia; studies on patients treated with these substances over a ten year period.恶性贫血中的叶酸和维生素B12;对使用这些物质治疗十年的患者的研究。
J Lab Clin Med. 1959 Jan;53(1):22-38.
9
Treatment of nutritional anemia in infants.婴儿营养性贫血的治疗。
Calif Med. 1952 May;76(5):346-9.
10
[Mechanism of action of folic acid and vitamin B12 in the treatment of megaloblastic anemia].[叶酸和维生素B12治疗巨幼细胞贫血的作用机制]
Sang. 1952;23(5):400-17.

本文引用的文献

1
Pathogenesis of megaloblastic anemia in infancy; an interrelationship between pteroglutamic acid and ascorbic acid.婴儿巨幼细胞贫血的发病机制;蝶酰谷氨酸与抗坏血酸之间的相互关系。
Am J Dis Child (1911). 1950 Aug;80(2):191-206. doi: 10.1001/archpedi.1950.04040020200001.
2
Oral treatment of pernicious anemia with subminimal doses of folic acid and vitamin B12.用小剂量叶酸和维生素B12口服治疗恶性贫血。
Am J Clin Pathol. 1950 May;20(5):454-7. doi: 10.1093/ajcp/20.5.454.
3
Studies on the relationships of vitamin B12, folic acid, thymine, uracil and methyl group donors in persons with pernicious anemia and related megaloblastic anemias.恶性贫血及相关巨幼细胞贫血患者体内维生素B12、叶酸、胸腺嘧啶、尿嘧啶及甲基供体之间关系的研究。
Blood. 1950 Aug;5(8):695-717.
4
The long-term evaluation of folic acid in the treatment of pernicious anemia.
J Lab Clin Med. 1950 Jun;35(6):894-8.
5
Vitamin B12 in macrocytic anaemia of pregnancy and the puerperium.维生素B12与妊娠及产褥期巨幼细胞贫血
Br Med J. 1950 Apr 22;1(4659):924-7. doi: 10.1136/bmj.1.4659.924.
6
Vitamin B12 and folic acid in megaloblastic anaemias of pregnancy and the puerperium.孕期及产褥期巨幼细胞贫血中的维生素B12和叶酸
Br Med J. 1950 Apr 22;1(4659):919-24. doi: 10.1136/bmj.1.4659.919.
7
Megaloblastic anemia of infancy. Response to vitamin B12.
Blood. 1950 May;5(5):458-67.
8
Vitamin B12 and related factors: a clinical and experimental review.维生素B12及相关因素:临床与实验综述
Edinb Med J. 1950 Feb;57(2):72-109.
9
Variable response to vitamin B12 of megaloblastic anemia of infancy.婴儿巨幼细胞贫血对维生素B12的反应各异。
Pediatrics. 1949 Dec;4(6):723-9.
10
The intravenous use of high molecular ferric carbohydrate compound in the treatment of hypochromic anemia.高分子碳水化合物铁化合物静脉注射治疗低色素性贫血
Blood. 1952 Mar;7(3):358-67.

新型补血药及其使用与滥用

The newer hematinics, their use and abuse.

作者信息

LUTTGENS W F

出版信息

Calif Med. 1952 Dec;77(6):369-73.

PMID:13009494
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1521536/
Abstract

The newer hematinics are merely refinements of preexisting forms of treatment, but they have aided particularly in a better understanding of the deficiency states. The intrinsic factor of Castle has not been isolated from the gastric juice, and the interrelationships of this substance with the extrinsic factor (vitamin B(12)) and folic acid have not been defined at this time. Vitamin B(12) appears to be the active principle of refined liver extract and alone is probably adequate treatment for pernicious anemia. The other varieties of megaloblastic anemia may result from deficiency of vitamin B(12) or folic acid, although generally treatment with the latter brings about complete and lasting remission. The use of multihematinics and multivitamin preparations containing folic acid is to be condemned, particularly because of the possibility of their obscuring anemia and thwarting diagnosis of pernicious anemia until neurologic complications have taken place. Saccharated oxide of iron is a relatively safe preparation for intravenous administration, but the indications for its use are few. Because the body has no mechanism for iron excretion, only the amount of iron necessary to make up a deficiency should be given, although there is no definite evidence that hemochromatosis results from overdosage.

摘要

新型补血剂只是对原有治疗形式的改进,但它们尤其有助于更好地理解营养缺乏状态。卡斯尔氏内因子尚未从胃液中分离出来,目前该物质与外因子(维生素B12)和叶酸之间的相互关系也尚未明确。维生素B12似乎是精制肝提取物的活性成分,单独使用可能对恶性贫血有足够的治疗效果。其他类型的巨幼细胞贫血可能是由于维生素B12或叶酸缺乏所致,尽管一般来说,使用后者治疗可带来完全且持久的缓解。应谴责使用含有叶酸的多种补血剂和多种维生素制剂,特别是因为它们可能掩盖贫血症状,阻碍恶性贫血的诊断,直到出现神经并发症。含糖氧化铁是一种相对安全的静脉给药制剂,但其使用指征较少。由于人体没有铁排泄机制,应仅给予弥补缺乏所需的铁量,尽管尚无确凿证据表明血色素沉着症是由过量用药引起的。